Skip to main content

IGF-1 and IGFBP3 as indirect markers of hepatic insulin resistance and their relation to metabolic syndrome parameters in liver steatosis patients Cover

.blurhash-client-img { display: none !important; }

IGF-1 and IGFBP3 as indirect markers of hepatic insulin resistance and their relation to metabolic syndrome parameters in liver steatosis patients

Endocrine Regulations

Volume 57 (2023): Issue 1 (January 2023)

By: Emil Fraenkel and Ivica Lazurova

Open Access

|May 2023

Download Article

Download the full article as a PDF file.

Articles in this issue

DOI: https://doi.org/10.2478/enr-2023-0009 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668

Journal RSS Feed

Language: English

Page range: 69 - 79

Published on: May 15, 2023

Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

insulin resistance,

liver steatosis

Related subjects:

Molecular biology,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Internal medicine,

Endocrinology, diabetology

© 2023 Emil Fraenkel, Ivica Lazurova, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 57 (2023): Issue 1 (January 2023)

Previous article